Brief: Bavarian Nordic Receives Authorization For Chikungunya Vaccine In UK
May 2 (Reuters) - Bavarian Nordic A/S BAVA.CO: BAVARIAN NORDIC RECEIVES MARKETING AUTHORIZATION FOR CHIKUNGUNYA VACCINE FOR PERSONS AGED 12 AND OLDER IN THE UNITED KINGDOM Source text: ID:nGNE8tKwn8 Further company coverage: BAVA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Gets Smallpox/Mpox Vaccine Supply Contract
Brief: Bavarian Nordic Secures Additional Government Contract For The Supply Of Smallpox/Mpox Vaccine
Brief: Bavarian Nordic Launches Final Tranche Of Buy-Back Program
Bavarian Nordic falls as high costs, lower vaccine sales hit Q1 results
Bavarian Nordic Q1 revenue falls as Public Preparedness unit sales decline